Coronavirus: Hong Kong experts push for Johnson & Johnson vaccine to replace AstraZeneca after report; city expects about 10 cases, mostly imported
Published
Apr 08 2021 at 5:14 AM GMT
Key
Points
Points
- Hong Kong medical experts have called on the government to replace its procurement of AstraZeneca with the jabs developed by Johnson & Johnson amid safety concerns over the possible link between the British-Swedish vaccine and blood clots.
- The city was expected to add about 10 coronavirus cases on Thursday, according to a medical source, with most of those imported, a continuation of an ongoing trend.
- The city’s case tally stood at 11,539, with 205 related deaths, as of Wednesday.
Trending
Stats
- Published Apr 8, 2021 5:14 AM GMT